• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过强化灌注细胞培养提高对称双特异性抗体的生产力和质量

Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture.

作者信息

Qin Yongjun, Ma Rongmei, Li Yang, Li Yifeng, Chen Gong, Zhou Weichang

机构信息

Technology and Process Development (TPD), WuXi Biologics, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China.

Biologics Development, WuXi Biologics, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China.

出版信息

Antib Ther. 2022 May 3;5(2):111-120. doi: 10.1093/abt/tbac009. eCollection 2022 Apr.

DOI:10.1093/abt/tbac009
PMID:35719210
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9199187/
Abstract

BACKGROUND

Aggregation, fragmentation, and low yield are issues frequently found during the cell culture process of bispecific antibodies (bsAbs), whose inherent complexity likely plays a role in causing these issues.

METHODS

In this study, we made a head-to-head comparison between fed-batch cell culture and intensified perfusion cell culture with a symmetric bsAb case.

RESULTS

In comparison with the fed-batch culture, a 6.6-fold improvement in integrated viable cell density and a 10.9-fold improvement in volumetric productivity were achieved with the intensified perfusion mode. In addition, a significant decrease in aggregation and fragmentation was observed with the intensified perfusion cell culture. Furthermore, product homogeneity was improved, which was reflected by the increased percentage of capillary isoelectric focusing main group. The quality improvement with intensified perfusion cell culture can be attributed to the shortened product retention in the bioreactor.

CONCLUSIONS

These findings suggest that intensified perfusion cell culture could be a better choice than traditional fed-batch especially for complex molecules like bsAbs. As this is a single case report, future studies on other cases are needed to further confirm the general applicability of this strategy.

摘要

背景

双特异性抗体(bsAbs)细胞培养过程中经常出现聚集、片段化和低产量问题,其内在复杂性可能是导致这些问题的原因之一。

方法

在本研究中,我们对补料分批细胞培养和强化灌注细胞培养在一种对称双特异性抗体情况下进行了直接比较。

结果

与补料分批培养相比,强化灌注模式下的综合活细胞密度提高了6.6倍,体积生产力提高了10.9倍。此外,强化灌注细胞培养中聚集和片段化显著减少。此外,产品均一性得到改善,这通过毛细管等电聚焦主峰百分比的增加得以体现。强化灌注细胞培养带来的质量提升可归因于生物反应器中产品保留时间的缩短。

结论

这些发现表明,强化灌注细胞培养可能是比传统补料分批培养更好的选择,特别是对于像双特异性抗体这样的复杂分子。由于这是一个单病例报告,需要对其他病例进行进一步研究以进一步确认该策略的普遍适用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b647/9199187/77b0d30bc12c/tbac009f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b647/9199187/08d35bc0ad96/tbac009f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b647/9199187/cc32115d3b40/tbac009f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b647/9199187/a22141ebdb2f/tbac009f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b647/9199187/adbea64e16d5/tbac009f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b647/9199187/d73316411897/tbac009f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b647/9199187/ff36792a3088/tbac009f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b647/9199187/77b0d30bc12c/tbac009f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b647/9199187/08d35bc0ad96/tbac009f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b647/9199187/cc32115d3b40/tbac009f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b647/9199187/a22141ebdb2f/tbac009f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b647/9199187/adbea64e16d5/tbac009f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b647/9199187/d73316411897/tbac009f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b647/9199187/ff36792a3088/tbac009f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b647/9199187/77b0d30bc12c/tbac009f7.jpg

相似文献

1
Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture.通过强化灌注细胞培养提高对称双特异性抗体的生产力和质量
Antib Ther. 2022 May 3;5(2):111-120. doi: 10.1093/abt/tbac009. eCollection 2022 Apr.
2
Improving product quality and productivity of bispecific molecules through the application of continuous perfusion principles.通过应用连续灌注原理提高双特异性分子的产品质量和生产力。
Biotechnol Prog. 2020 Jul;36(4):e2973. doi: 10.1002/btpr.2973. Epub 2020 Feb 13.
3
Perfusion CHO cell culture applied to lower aggregation and increase volumetric productivity for a bispecific recombinant protein.灌注 CHO 细胞培养降低聚集并提高双特异性重组蛋白的体积产率。
J Biotechnol. 2019 Oct 10;304:70-77. doi: 10.1016/j.jbiotec.2019.08.001. Epub 2019 Aug 2.
4
Developing an ultra-intensified fed-batch cell culture process with greatly improved performance and productivity.开发一种超强化补料分批细胞培养工艺,具有显著提高的性能和生产力。
Biotechnol Bioeng. 2024 Feb;121(2):696-709. doi: 10.1002/bit.28605. Epub 2023 Nov 23.
5
Impact of fed-batch process intensification on the productivity and product quality of two CHO cell lines expressing unique novel molecular format proteins.补料分批培养过程强化对两种表达独特新型分子形式蛋白的中国仓鼠卵巢细胞系的生产力和产品质量的影响。
Bioprocess Biosyst Eng. 2024 Aug;47(8):1227-1240. doi: 10.1007/s00449-024-02997-3. Epub 2024 Apr 23.
6
Intensified perfusion culture (IPC) reduced recombinant protein fragmentation.强化灌注培养(IPC)减少了重组蛋白的碎片化。
Biotechnol Prog. 2024 Mar-Apr;40(2):e3405. doi: 10.1002/btpr.3405. Epub 2023 Nov 24.
7
Process intensification to produce a difficult-to-express therapeutic enzyme by high cell density perfusion or enhanced fed-batch.通过高密度灌注或强化补料分批培养来实现生产表达困难的治疗性酶的过程强化。
Biotechnol Bioeng. 2021 Sep;118(9):3533-3544. doi: 10.1002/bit.27806. Epub 2021 May 13.
8
Bioreactor productivity and media cost comparison for different intensified cell culture processes.不同强化细胞培养工艺的生物反应器生产力与培养基成本比较
Biotechnol Prog. 2017 Jul;33(4):867-878. doi: 10.1002/btpr.2415. Epub 2017 Jan 28.
9
A comparison of different intensified upstream processes highlighting the advantage of WuXi Biologics' Ultra-high Productivity platform (WuXiUP) in improved product quality and purification yield.不同强化上游工艺的比较,突出了药明生物的超高生产力平台(WuXiUP)在提高产品质量和纯化收率方面的优势。
Biotechnol Prog. 2024 Nov-Dec;40(6):e3487. doi: 10.1002/btpr.3487. Epub 2024 Jul 9.
10
Perfusion cell culture for the production of conjugated recombinant fusion proteins reduces clipping and quality heterogeneity compared to batch-mode processes.与批处理模式相比,灌注细胞培养生产缀合重组融合蛋白可减少剪接和质量异质性。
J Biotechnol. 2019 Aug 20;302:26-31. doi: 10.1016/j.jbiotec.2019.06.006. Epub 2019 Jun 15.

引用本文的文献

1
Engineering and physicochemical characterization of a novel, stable, symmetric bispecific antibody with dual target-binding using a common light chain.新型稳定对称双特异性抗体的工程和物理化学特性研究,该抗体采用通用轻链实现双靶位结合。
Protein Sci. 2024 Oct;33(10):e5121. doi: 10.1002/pro.5121.
2
Establishment of a semi-continuous scale-down clone screening model for intensified perfusion culture.建立强化灌注培养半连续缩小克隆筛选模型。
Biotechnol Lett. 2024 Dec;46(6):1085-1093. doi: 10.1007/s10529-024-03512-0. Epub 2024 Jul 27.
3
Recombinant therapeutic proteins degradation and overcoming strategies in CHO cells.

本文引用的文献

1
Improving an intensified and integrated continuous bioprocess platform for biologics manufacturing.改进用于生物制品生产的强化和集成连续生物工艺平台。
Biotechnol Bioeng. 2021 Sep;118(9):3618-3623. doi: 10.1002/bit.27768. Epub 2021 Apr 14.
2
Understanding the effect of increased cell specific productivity on galactosylation of monoclonal antibodies produced using Chinese hamster ovary cells.了解提高细胞比生产率对中国仓鼠卵巢细胞生产的单克隆抗体糖基化的影响。
J Biotechnol. 2021 Mar 10;329:92-103. doi: 10.1016/j.jbiotec.2021.01.023. Epub 2021 Feb 4.
3
Bispecific monoclonal antibodies for targeted immunotherapy of solid tumors: Recent advances and clinical trials.
CHO 细胞中重组治疗蛋白的降解及克服策略。
Appl Microbiol Biotechnol. 2024 Jan 29;108(1):182. doi: 10.1007/s00253-024-13008-6.
4
WAVE-based intensified perfusion cell culture for fast process development.基于波导的强化灌注细胞培养用于快速工艺开发。
Biotechnol Lett. 2023 Sep;45(9):1117-1131. doi: 10.1007/s10529-023-03405-8. Epub 2023 Jun 29.
双特异性单克隆抗体用于实体瘤的靶向免疫治疗:最新进展和临床试验。
Int J Biol Macromol. 2021 Jan 15;167:1030-1047. doi: 10.1016/j.ijbiomac.2020.11.058. Epub 2020 Nov 14.
4
Perfusion reduces bispecific antibody aggregation via mitigating mitochondrial dysfunction-induced glutathione oxidation and ER stress in CHO cells.灌流通过减轻线粒体功能障碍诱导的谷胱甘肽氧化和 ER 应激来减少双特异性抗体聚集。
Sci Rep. 2020 Oct 6;10(1):16620. doi: 10.1038/s41598-020-73573-4.
5
Improving product quality and productivity of bispecific molecules through the application of continuous perfusion principles.通过应用连续灌注原理提高双特异性分子的产品质量和生产力。
Biotechnol Prog. 2020 Jul;36(4):e2973. doi: 10.1002/btpr.2973. Epub 2020 Feb 13.
6
Perfusion CHO cell culture applied to lower aggregation and increase volumetric productivity for a bispecific recombinant protein.灌注 CHO 细胞培养降低聚集并提高双特异性重组蛋白的体积产率。
J Biotechnol. 2019 Oct 10;304:70-77. doi: 10.1016/j.jbiotec.2019.08.001. Epub 2019 Aug 2.
7
Perfusion cell culture for the production of conjugated recombinant fusion proteins reduces clipping and quality heterogeneity compared to batch-mode processes.与批处理模式相比,灌注细胞培养生产缀合重组融合蛋白可减少剪接和质量异质性。
J Biotechnol. 2019 Aug 20;302:26-31. doi: 10.1016/j.jbiotec.2019.06.006. Epub 2019 Jun 15.
8
A brief introduction of IgG-like bispecific antibody purification: Methods for removing product-related impurities.IgG样双特异性抗体纯化简介:去除产品相关杂质的方法。
Protein Expr Purif. 2019 Mar;155:112-119. doi: 10.1016/j.pep.2018.11.011. Epub 2018 Dec 1.
9
Larger Pore Size Hollow Fiber Membranes as a Solution to the Product Retention Issue in Filtration-Based Perfusion Bioreactors.大孔径中空纤维膜解决基于过滤的灌流生物反应器中的产物滞留问题。
Biotechnol J. 2019 Feb;14(2):e1800137. doi: 10.1002/biot.201800137. Epub 2018 Dec 13.
10
Perfusion Cell Culture Decreases Process and Product Heterogeneity in a Head-to-Head Comparison With Fed-Batch.灌流细胞培养与分批培养的头对头比较降低了工艺和产品的异质性。
Biotechnol J. 2019 Feb;14(2):e1700733. doi: 10.1002/biot.201700733. Epub 2018 Jun 25.